These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29396516)

  • 1. RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma.
    Yang Q; Lin W; Liu Z; Zhu J; Huang N; Cui Z; Han Z; Pan Q; Goel A; Sun F
    Cell Death Dis; 2018 Feb; 9(2):146. PubMed ID: 29396516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response.
    Li Y; Luo K; Yin Y; Wu C; Deng M; Li L; Chen Y; Nowsheen S; Lou Z; Yuan J
    Nat Commun; 2017 Jun; 8():15752. PubMed ID: 28569838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response.
    Yan J; Kim YS; Yang XP; Li LP; Liao G; Xia F; Jetten AM
    Cancer Res; 2007 Jul; 67(14):6647-56. PubMed ID: 17621610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites.
    Yan J; Jetten AM
    Cancer Lett; 2008 Nov; 271(2):179-90. PubMed ID: 18550271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response.
    Kim H; Chen J; Yu X
    Science; 2007 May; 316(5828):1202-5. PubMed ID: 17525342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.
    Shao G; Patterson-Fortin J; Messick TE; Feng D; Shanbhag N; Wang Y; Greenberg RA
    Genes Dev; 2009 Mar; 23(6):740-54. PubMed ID: 19261746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage.
    Wang B; Elledge SJ
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20759-63. PubMed ID: 18077395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
    Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
    Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAP80 responds to DNA damage induced by both ionizing radiation and UV irradiation and is phosphorylated at Ser 205.
    Yan J; Yang XP; Kim YS; Jetten AM
    Cancer Res; 2008 Jun; 68(11):4269-76. PubMed ID: 18519686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of JAMM domain deubiquitinating enzyme activity within the RAP80 complex.
    Patterson-Fortin J; Shao G; Bretscher H; Messick TE; Greenberg RA
    J Biol Chem; 2010 Oct; 285(40):30971-81. PubMed ID: 20656689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The de-ubiquitylating enzymes USP26 and USP37 regulate homologous recombination by counteracting RAP80.
    Typas D; Luijsterburg MS; Wiegant WW; Diakatou M; Helfricht A; Thijssen PE; van den Broek B; Mullenders LH; van Attikum H
    Nucleic Acids Res; 2015 Aug; 43(14):6919-33. PubMed ID: 26101254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
    BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding.
    Goldstein M; Kastan MB
    Cancer Res; 2015 Jul; 75(13):2699-707. PubMed ID: 25939603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage.
    Guzzo CM; Berndsen CE; Zhu J; Gupta V; Datta A; Greenberg RA; Wolberger C; Matunis MJ
    Sci Signal; 2012 Dec; 5(253):ra88. PubMed ID: 23211528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk1 protein-mediated phosphorylation of receptor-associated protein 80 (RAP80) serine 677 modulates DNA damage-induced G2/M checkpoint and cell survival.
    Cho HJ; Oh YJ; Han SH; Chung HJ; Kim CH; Lee NS; Kim WJ; Choi JM; Kim H
    J Biol Chem; 2013 Feb; 288(6):3768-76. PubMed ID: 23264621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection.
    Kakarougkas A; Ismail A; Katsuki Y; Freire R; Shibata A; Jeggo PA
    Nucleic Acids Res; 2013 Dec; 41(22):10298-311. PubMed ID: 24013561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma.
    Sha B; Sun Y; Zhao S; Li M; Huang W; Li Z; Shi J; Han X; Li P; Hu T; Chen P
    Cell Biol Toxicol; 2023 Oct; 39(5):2011-2032. PubMed ID: 35022897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.